Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. QIAGEN N.V.
  6. News
  7. Summary
    QGEN   NL0012169213


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

DGAP-PVR : QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

05/04/2021 | 04:04pm EDT
DGAP Voting Rights Announcement: QIAGEN N.V. 
QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the 
objective of Europe-wide distribution 
2021-05-04 / 22:03 
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
The AFM (the Netherlands Authority For the Financial Markets) has informed us on April 29, 2021 that a notification 
related to our institution has been released by the AFM. 
The following notification has been disclosed in the relevant register on the AFM website: 
Date of transaction: 27 apr 2021 
Person obliged to notify: BlackRock, Inc. 
Issuing institution: Qiagen N.V. 
Registration Chamber of Commerce: 12036979 
Place of residence: VENLO 
Distribution in numbers 
Type of share       Number of     Number of voting    Capital       Voting      Manner of disposal      Settlement 
                    shares        rights              interest      rights 
                    32.029.671,00 34.487.155,00                                 Indirectly - BlackRock, 
Ordinary share                                        Real          Real        Inc. 
                                                                                Indirectly - BlackRock, Physical 
Ordinary share      938.974,00    938.974,00          Potential     Potential   Inc.                    Delivery 
Contract for                                                                    Indirectly - BlackRock, In Cash 
difference          290.149,00    290.149,00          Potential     Potential   Inc. Distribution in percentages 
Type             Total holding Directly real Directly potential Indirectly real Indirectly potential 
Capital interest 14,41 %       0,00 %        0,00 %             13,88 %         0,53 % 
Voting rights    15,47 %       0,00 %        0,00 %             14,94 %         0,53 % 

QIAGEN N.V. is not responsible for the accuracy and correctness of the notification above. The content has been taken from the relevant register of the AFM: https://www.afm.nl/en/professionals/registers/meldingenregisters/substantiele-deelnemingen/details?id=110476 -----------------------------------------------------------------------------------------------------------------------

2021-05-04 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de -----------------------------------------------------------------------------------------------------------------------

Language:     English 
Company:      QIAGEN N.V. 
              Hulsterweg 82 
              5912 PL Venlo 
Internet:     www.qiagen.com 
End of News   DGAP News Service 

1191122 2021-05-04

Image link: 

(END) Dow Jones Newswires

May 04, 2021 16:03 ET (20:03 GMT)

All news about QIAGEN N.V.
05/07DGAP-PVR  : QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG ..
05/06QIAGEN N  : Clinical Laboratory Tests Market To Demonstrate Massive Growth By 20..
05/06QIAGEN NV  : Buy rating from Deutsche Bank
05/05QIAGEN NV  : Receives a Buy rating from Kepler Cheuvreux
05/05QIAGEN N  : And subsidiaries u.s. gaap quarterly report for the period ended mar..
05/05QIAGEN N  : Chief Financial Officer
05/05DGAP-CMS  : QIAGEN N.V.: Release according to Article 50 of the WpHG [the German..
05/05QIAGEN N.V. : Release according to Article 50 of the WpHG [the German Securities..
05/04DGAP-PVR  : QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG ..
05/04QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German..
More news
Financials (USD)
Sales 2021 2 268 M - -
Net income 2021 482 M - -
Net Debt 2021 802 M - -
P/E ratio 2021 22,6x
Yield 2021 -
Capitalization 10 897 M 10 897 M -
EV / Sales 2021 5,16x
EV / Sales 2022 5,11x
Nbr of Employees 5 750
Free-Float 93,0%
Duration : Period :
QIAGEN N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QIAGEN N.V.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 58,33 $
Last Close Price 47,64 $
Spread / Highest target 51,1%
Spread / Average Target 22,4%
Spread / Lowest Target -13,9%
EPS Revisions
Managers and Directors
Thierry Bernard Chief Executive Officer & Managing Director
Roland Sackers Chief Financial Officer & Managing Director
Lawrence A. Rosen Chairman-Supervisory Board
Barthold Piening Senior Vice President & Head-Global Operations
Metin Colpan Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
QIAGEN N.V.-9.86%10 897
MODERNA, INC.56.17%65 346
LONZA GROUP AG1.51%47 533
CELLTRION, INC.-25.77%32 687
SEAGEN INC.-20.36%25 314